Abstract:Background and objectives Nocturnal hypertension is associated with adverse outcomes in patients with CKD. However, the individual association of entities of nocturnal hypertension according to achievement of systolic and/or diastolic BP goals with kidney failure and cardiovascular outcomes of CKD is not clear. Design, setting, participants, & measurements Our study analyzed data from participants in the Chinese Cohort Study of Chronic Kidney Disease. Nocturnal hypertension was categorized into three entities: isolated nocturnal diastolic hypertension with diastolic BP ≥70 mm Hg and systolic BP <120 mm Hg, isolated nocturnal systolic hypertension with systolic BP ≥120 mm Hg and diastolic BP <70 mm Hg, and nocturnal systolic-diastolic hypertension with both systolic BP ≥120 mm Hg and diastolic BP ≥70 mm Hg. Associations of nocturnal hypertension entities with kidney failure and cardiovascular outcomes were evaluated by Cox regression. Results In total, 2024 patients with CKD stages 1–4 were included in our analysis (mean age, 49±14 years; 57% men; eGFR=51±29 ml/min per 1.73 m 2 ; proteinuria: 0.9 [0.4–2.1] g/d). Among them, 1484 (73%) patients had nocturnal hypertension, with the proportions of 26%, 8%, and 66% for isolated nocturnal diastolic hypertension, isolated nocturnal systolic hypertension, and nocturnal systolic-diastolic hypertension, respectively. Three hundred twenty kidney events and 148 cardiovascular events were recorded during median follow-up intervals of 4.8 and 5.0 years for kidney and cardiovascular events, respectively. After adjustment, isolated nocturnal systolic hypertension was associated with a higher risk for cardiovascular events (hazard ratio, 3.17; 95% confidence interval, 1.61 to 6.23). Nocturnal systolic-diastolic hypertension showed a higher risk for both kidney failure (hazard ratio, 1.71; 95% confidence interval, 1.17 to 2.49) and cardiovascular outcomes (hazard ratio, 2.19; 95% confidence interval, 1.24 to 3.86). No association was observed between isolated nocturnal diastolic hypertension with either kidney failure or cardiovascular events. Conclusions Nocturnal systolic hypertension, either alone or in combination with diastolic hypertension, is associated with higher risks for adverse outcomes in patients with CKD. Visual

Association of Morning Hypertension with Chronic Kidney Disease Progression and Cardiovascular Events in Patients with Chronic Kidney Disease and Hypertension

The Association of Morning Hypertension With Target Organ Damage in Patients With Chronic Kidney Disease and Hypertension

Prognostic effect of masked morning hypertension in Chinese inpatients with non-dialysis chronic kidney disease: A multi-center retrospective study

Blood Pressure Characteristics in Moderate to Severe Renal Insufficiency

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Prognostic value of morning blood pressure surge in chronic kidney disease

Association of Central Arterial Blood Pressure and Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease

Chronic Kidney Disease and Left Ventricular Hypertrophy. Potent Modifiers of the Prognostic Impact of Circadian Blood Pressure Changes

Association of cardiovascular health metrics with all-cause and cardiovascular disease mortality in CKD: a cohort study

Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD

Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults

Nocturnal Hypertension in Children With Chronic Kidney Disease Is Common and Associated With Progression to Kidney Replacement Therapy

Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1–4 patients

COMPARISONS OF THE PREDICTIVE VALUE OF MORNING AND EVENING BLOOD PRESSURE FOR NOCTURNAL HYPERTENSION AND MORNING BLOOD PRESSURE SURGE

Control of hypertension in patients with chronic kidney disease and its associated factors

Morning hypertension is more common in elderly hypertensive patients with controlled documented office blood pressure in primary care clinics: the Minhang study

A quantitative assay for DNA-DNA hybrids using membrane filters.

Role of home blood pressure monitoring in chronic kidney disease

Study of the Relation Between Blood Pressure Parameters and Urine Microprotein in Essential Hypertension Subjects

Nighttime Blood Pressure Control in Hypertensive Chinese Chronic Kidney Disease Patients

Prevalence and factors associated with masked hypertension in chronic kidney disease